| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/02/1999 | CA2332402A1 Novel 2-alkyl substituted imidazole compounds |
| 12/02/1999 | CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract |
| 12/02/1999 | CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 12/02/1999 | CA2332318A1 G-csf mimetics |
| 12/02/1999 | CA2332317A1 G-csf mimetics |
| 12/02/1999 | CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof |
| 12/02/1999 | CA2331056A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 12/02/1999 | CA2330620A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
| 12/02/1999 | CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene |
| 12/02/1999 | CA2329159A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 12/02/1999 | CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 12/02/1999 | CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 12/02/1999 | CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor |
| 12/02/1999 | CA2328894A1 Methods and products for inducing mucosal immunity |
| 12/02/1999 | CA2321927A1 Treatment of c. difficile toxin b associated conditions |
| 12/02/1999 | CA2298982A1 Disinfectant composition |
| 12/01/1999 | EP0960941A1 Gene Therapy for cell proliferative diseases |
| 12/01/1999 | EP0960884A1 Process for the production of 3,7-dialkylxanthins from 3-alkylxanthins |
| 12/01/1999 | EP0960883A1 Substituted thiazolidinedione derivatives |
| 12/01/1999 | EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 12/01/1999 | EP0960880A1 Process for preparing intermediates to nizatidine and related compounds |
| 12/01/1999 | EP0960621A2 Pharmaceutical formulations comprising sildenafil |
| 12/01/1999 | EP0960620A1 A stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole |
| 12/01/1999 | EP0960619A1 Sustained release analgesic compositions comprising tilidine |
| 12/01/1999 | EP0960618A2 Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 12/01/1999 | EP0960572A1 Nutritional composition for the treatment of pressure ulcers |
| 12/01/1999 | EP0960567A2 Fat based food products |
| 12/01/1999 | EP0960335A2 Modulators of insulin receptor activity |
| 12/01/1999 | EP0960208A1 Glutathione s-transferase (gst) genes in cancer |
| 12/01/1999 | EP0960141A1 Cross-linked vinyl polymers with bile acid adsorbing effect |
| 12/01/1999 | EP0960139A1 Elastomer treatment process to decrease peroxide levels |
| 12/01/1999 | EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 12/01/1999 | EP0960121A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 12/01/1999 | EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE |
| 12/01/1999 | EP0960119A1 T cell antigen receptor peptides |
| 12/01/1999 | EP0960118A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 12/01/1999 | EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 12/01/1999 | EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE |
| 12/01/1999 | EP0960111A1 Morphine derivatives with analgesic activity |
| 12/01/1999 | EP0960110A1 3-ARYL SUBSTITUTED PYRAZOLO 4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF 1?) SPECIFIC LIGANDS |
| 12/01/1999 | EP0960108A1 Matrix metalloproteinase inhibitors |
| 12/01/1999 | EP0960107A1 6-thio-substituted paclitaxels |
| 12/01/1999 | EP0960106A1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 12/01/1999 | EP0960105A1 Benzofurazan compounds which enhance ampa receptor activity |
| 12/01/1999 | EP0960104A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| 12/01/1999 | EP0960103A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors) |
| 12/01/1999 | EP0960102A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN |
| 12/01/1999 | EP0960101A1 4-aminoethoxyindazole derivatives |
| 12/01/1999 | EP0960098A1 Arylsulfonyl hydroxamic acid derivatives |
| 12/01/1999 | EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS |
| 12/01/1999 | EP0959905A2 Polysaccharide-peptide-conjugates |
| 12/01/1999 | EP0959903A1 NOVEL FabD |
| 12/01/1999 | EP0959898A1 Lactoferrin variants and uses thereof |
| 12/01/1999 | EP0959896A2 Human thyrotropin receptor compositions and use thereof |
| 12/01/1999 | EP0959892A1 Use of pvp or povidone for reducing bowel distension |
| 12/01/1999 | EP0959891A1 Anthelmintic formulations |
| 12/01/1999 | EP0959890A1 Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives |
| 12/01/1999 | EP0959889A1 Methods and compositions to inhibit keratinocyte proliferation |
| 12/01/1999 | EP0959888A1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
| 12/01/1999 | EP0959887A1 Pharmaceutically active compounds and methods of use |
| 12/01/1999 | EP0959886A1 Triaryl substituted imidazoles as glucagon antagonists |
| 12/01/1999 | EP0959885A1 Triaryl substituted imidazoles and methods of use |
| 12/01/1999 | EP0959884A1 Phosphatase inhibitors and methods of use thereof |
| 12/01/1999 | EP0959883A1 Inhibitors of farnesyl-protein transferase |
| 12/01/1999 | EP0959882A1 N-linked ureas and carbamates of heterocyclic thioesters |
| 12/01/1999 | EP0959881A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom |
| 12/01/1999 | EP0959880A1 Pharmaceutical formulation |
| 12/01/1999 | EP0959879A1 Photodynamic therapy for the treatment of osteoarthritis |
| 12/01/1999 | EP0959878A1 Method for treating renal failure |
| 12/01/1999 | EP0959877A1 Correction of genetic defects using chemical chaperones |
| 12/01/1999 | EP0959876A2 Method for separating active substances in solid pharmaceutical preparations |
| 12/01/1999 | EP0959875A1 Active substance carrier for releasing apomorphine into the buccal cavity |
| 12/01/1999 | EP0959874A1 High dose liposomal aerosol formulations |
| 12/01/1999 | EP0959792A1 Spine distraction implant and method |
| 12/01/1999 | EP0959781A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 12/01/1999 | EP0850235B1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 12/01/1999 | EP0800504B1 Tricyclic retinoids, methods for their production and use |
| 12/01/1999 | EP0788491B1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
| 12/01/1999 | EP0740708A4 Design of drugs involving receptor-ligand-dna interactions |
| 12/01/1999 | EP0739201B1 Microgranules of 5-nitro imidazole derivatives |
| 12/01/1999 | EP0725642B1 Stabilized prostaglandin e 1 |
| 12/01/1999 | EP0697866B1 High dose formulations |
| 12/01/1999 | EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 12/01/1999 | EP0642503B1 10-desacetoxytaxol derivatives |
| 12/01/1999 | EP0630244B1 Muscarinic agonists |
| 12/01/1999 | EP0610519B1 Anti-hiv drug |
| 12/01/1999 | EP0582631B1 Use of S-nitrosothiols for the preparation of a medicament for the relaxation of smooth muscle |
| 12/01/1999 | EP0576612B1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 12/01/1999 | CN1237183A 6-0-substituted ketolides having antibacterial activity |
| 12/01/1999 | CN1237179A 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivatives |
| 12/01/1999 | CN1237178A Novel 'beta'-lactam compounds and process for preparing the same |
| 12/01/1999 | CN1237177A Fused bicyclic pyrimidine derivatives |
| 12/01/1999 | CN1237176A Tricyclic compounds useful as FPT inhibitors |
| 12/01/1999 | CN1237175A 2R, 4S, S, S- and 2S, 4R, S, S-hydroxyitraconazole |
| 12/01/1999 | CN1237174A 2R, 4S, S, R- and 2S, 4R, S, R-hydroxyitraconazole |
| 12/01/1999 | CN1237173A 2R, 4S, R, R- and 2S, 4R, R, R-hydroxyitraconazole |
| 12/01/1999 | CN1237172A 2R, 4S, R, S- and 2S, 4R, R, S-hydroxyitraconazole and hydroxysaperconazole |
| 12/01/1999 | CN1237171A Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 12/01/1999 | CN1237170A Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
| 12/01/1999 | CN1237169A Tricyclic compounds useful for inhibition of G-protein function and treatment of proliferative diseases |